Filter News
Area of Research
News Type
News Topics
- (-) Biomedical (29)
- (-) Cybersecurity (14)
- (-) Mercury (7)
- (-) Polymers (11)
- 3-D Printing/Advanced Manufacturing (39)
- Advanced Reactors (9)
- Artificial Intelligence (47)
- Big Data (25)
- Bioenergy (51)
- Biology (59)
- Biotechnology (12)
- Buildings (23)
- Chemical Sciences (24)
- Clean Water (15)
- Climate Change (52)
- Composites (7)
- Computer Science (86)
- Coronavirus (18)
- Critical Materials (2)
- Decarbonization (49)
- Education (1)
- Emergency (2)
- Energy Storage (34)
- Environment (107)
- Exascale Computing (25)
- Fossil Energy (4)
- Frontier (25)
- Fusion (31)
- Grid (25)
- High-Performance Computing (43)
- Hydropower (5)
- Isotopes (28)
- ITER (2)
- Machine Learning (23)
- Materials (41)
- Materials Science (51)
- Mathematics (6)
- Microelectronics (2)
- Microscopy (23)
- Molten Salt (1)
- Nanotechnology (20)
- National Security (37)
- Net Zero (8)
- Neutron Science (49)
- Nuclear Energy (58)
- Partnerships (14)
- Physics (31)
- Quantum Computing (18)
- Quantum Science (29)
- Renewable Energy (1)
- Security (12)
- Simulation (29)
- Software (1)
- Space Exploration (12)
- Summit (30)
- Sustainable Energy (46)
- Transformational Challenge Reactor (3)
- Transportation (32)
Media Contacts
Scientists at ORNL and the University of Wisconsin–Madison have discovered that genetically distinct populations within the same species of fungi can produce unique mixes of secondary metabolites, which are organic compounds with applications in
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.
Deborah Frincke, one of the nation’s preeminent computer scientists and cybersecurity experts, serves as associate laboratory director of ORNL’s National Security Science Directorate. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy
Belinda Akpa is a chemical engineer with a talent for tackling big challenges and fostering inclusivity and diversity in the next generation of scientists.
Rich Giannone uses bioanalytical mass spectrometry to examine proteins, the primary driver in biological systems.
When COVID-19 was declared a pandemic in March 2020, Oak Ridge National Laboratory’s Parans Paranthaman suddenly found himself working from home like millions of others.
The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.
The University of Texas at San Antonio (UTSA) has formally launched the Cybersecurity Manufacturing Innovation Institute (CyManII), a $111 million public-private partnership.
A multi-institutional team, led by a group of investigators at Oak Ridge National Laboratory, has been studying various SARS-CoV-2 protein targets, including the virus’s main protease. The feat has earned the team a finalist nomination for the Association of Computing Machinery, or ACM, Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research.
NellOne Therapeutics has licensed a drug delivery system from the Department of Energy’s Oak Ridge National Laboratory that is designed to transport therapeutics directly to cells infected by SARS-CoV-2, the virus causing COVID-19.